MedPath

A long term assessment for factors having an impact on the patency of saphenous vein graft following coronary artery bypass grafting

Not Applicable
Recruiting
Conditions
Ischemic cardiac disease(effort angina pectoris,asymptomatic myocardial ischemia,acute coronary syndrome
Registration Number
JPRN-UMIN000019062
Lead Sponsor
Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
25
Inclusion Criteria

Not provided

Exclusion Criteria

Patients meeting one of the following conditions will be excluded: 1) severe liver dysfunction 2) renal dysfunction (Cre>= 2.0mg/dL) 3) severe heart failure (NYHA/New York Heart Association stage III or severer) 4) malignancies or other diseases with poor prognosis 5) pregnant, lactating, and possibly pregnant women and those planning to become pregnant 6) judged as ineligible by clinical investigators

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The patency of saphenous vein graft one year after CABG
Secondary Outcome Measures
NameTimeMethod
1) Lumen area, intimal thickening and incidence of thrombus evaluated by OCT 2) Coronary flow velocity of saphenous vein graft 3) Value of inflammatory and vasoactive biomarker
© Copyright 2025. All Rights Reserved by MedPath